Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris limited, dublin array - 17227 solifenacin-sukcinÁt; 14672 tamsulosin-hydrochlorid - tableta s řízeným uvolňováním - 6mg/0,4mg - tamsulosin a solifenacin

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris limited, dublin array - 21421 agomelatin s kyselinou citronovou - potahovaná tableta - 25mg - agomelatin

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 543 epinefrin - injekční roztok v předplněném peru - 300mcg - epinefrin

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 543 epinefrin - injekční roztok v předplněném peru - 150mcg - epinefrin

Եվրոպական Միություն - չեխերեն - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris limited, dublin array - 15483 dutasterid; 14672 tamsulosin-hydrochlorid - tvrdá tobolka - 0,5mg/0,4mg - tamsulosin a dutasterid

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 9420 meloxikam - tableta - 15mg - meloxikam

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 2126 klindamycin-fosfÁt; 1958 tretinoin - gel - 10mg/g+0,25mg/g - tretinoin, kombinace

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 4992 theofylin - tvrdá tobolka s prodlouženým uvolňováním - 125mg - theofylin

Չեխիա - չեխերեն - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 4992 theofylin - tvrdá tobolka s prodlouženým uvolňováním - 250mg - theofylin